<?xml version="1.0" encoding="UTF-8"?>
<p id="p0455">Favilavir, formerly known as Fapilavir, was the first anti-novel coronavirus drug that has been approved for marketing by the National Medical Products Administration since the outbreak. The drug was developed by Zhejiang Hisun Pharmaceutical Company and is expected to play an important role in preventing and treating the epidemic [
 <xref rid="bib137" ref-type="bibr">137</xref>].
</p>
